Site Search

Share

X

Search Results

State Senate Committee Votes to Increase Access to Innovative Testing and Lifesaving Treatments

... here . Sacramento, Calif. –  The California Senate Health Committee voted Wednesday evening to advance a bill that would increase access to biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients.  Senate Bill 912 would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. The bill moves on to ...

More Californians with Cancer, Other Chronic Diseases, Get Access to Game-Changing Testing

... implementation of Senate Bill 496. Starting July 1st, Medi-Cal and other state-regulated health insurance plans will cover comprehensive  biomarker testing  when supported by medical and scientific evidence. Testing for specific biomarkers – such as gene mutations – found in blood, tissues ... including precision medicine and targeted therapies. “Nearly 60% of all cancer drugs approved in the last five years require or recommend biomarker testing before use. Improving coverage for biomarker testing across insurance types is a crucial step to reduce disparities in cancer ...

Legislation Introduced to Increase New Jerseyans’ Access to Biomarker Testing, the Key to Precision Medicine

Last week, legislation that seeks to improve New Jerseyans’ access to biomarker testing was introduced in the Legislature. Biomarker testing helps connect cancer patients to the right treatment at the right time, often resulting in improved outcomes and quality of life. ...

Oncologists to Visit New York State Capitol & Urge Legislators to Improve Access to Biomarker Testing

... and cancer survivors from across New York will gather at the Capitol building on Wednesday, May 17 to answer lawmakers’ questions about biomarker testing and ask for their support of Senate Bill 1196 / Assembly Bill 1673, which aim to improve New Yorkers’ access to biomarker testing – a tool that opens the door to precision medicine.   WHAT:   Improving Access to Biomarker Testing: Opportunity to ...

Advocates to Urge State Lawmakers to Pass Biomarker Testing Bill at Annual Cancer Action Day

... Tennessee will travel to the state Capitol next Tuesday, February 11, to meet with lawmakers and ask for their support in ensuring coverage of biomarker testing. The bills ( HB0484 and SB0435 ) to ensure coverage were introduced on January 28. In the case of a cancer diagnosis, biomarker testing helps doctors determine the right therapy or treatment, saving some patients from more generalized treatments like chemo and ...

Legislative Action Needed to Expand Access to Biomarker Testing, ‘Game-Changer’ in Fight Against Cancer

... passing legislation to ease the burden of cancer on Nebraskans. “ACS CAN calls on the legislature to improve coverage of comprehensive biomarker testing, a game changer in the fight against cancer. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a person’s own genes or proteins to better diagnose and treat diseases like cancer. Biomarker testing is an important step to accessing precision medicine which includes targeted therapies that can lead to improved survivorship and ...

Governor Abbott Signs Legislation that Improves Access to Precision Testing for More Texans

... Greg Abbott signed legislation that will improve access to care for cancer patients and people with other conditions by expanding coverage for biomarker testing. Senate Bill 989 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.     “ACS CAN thanks Sen. Joan Huffman and Rep. Greg Bonnen for ...

Senate Introduces Legislation to Increase Californians’ Access to Lifesaving Testing and Innovative Treatments

Sacramento, Calif. — Today, State Senator Monique Limón (D-Santa Barbara) introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient.  The American Cancer Society Cancer Action Network (ACS CAN) and ... Cancer Centers. “Last year, I authored legislation to provide patients diagnosed with stages 3 and 4 cancer with prompt access to biomarker testing to inform their course of treatment. We know there are biomarker testing available for other conditions that can help healthcare ...

Arizona House of Representatives Passes Legislation to Increase Access to Innovative Testing and Lifesaving Treatments

Phoenix, Ariz. – Today, the House of Representatives passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. House Bill 2144 aims to enable more Arizonans to benefit from biomarker testing, a critical step in accessing precision medicine treatments. The bill now heads to the Senate. Dubbed ‘the right treatment, to ...

Comprehensive Genomic Testing for Lung Cancer Patients: Pathologist-Driven Solutions

LUNGevity and ACS CAN partnered with Bruce Quinn Associates to develop materials to engage hospitals on pathologist-initiated biomarker testing, providing an overview of the MolDx clarification on CMS "treating physician" guidance. Comprehensive Genomic Testing for Lung Cancer Patients: Pathologist-Driven Solutions ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy